status epilepticus
Information
- Disease name
- status epilepticus
- Disease ID
- DOID:1824
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04391569 | Active, not recruiting | Phase 3 | Randomized Therapy In Status Epilepticus | October 10, 2020 | November 30, 2024 |
| NCT03905798 | Completed | LORA-PITA IV General Investigation | November 18, 2019 | November 15, 2023 | |
| NCT04333082 | Completed | Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction | April 22, 2020 | August 3, 2022 | |
| NCT00318578 | Completed | Prognosis Factors Associated With Convulsive Status Epilepticus in Adults | March 2005 | January 2007 | |
| NCT06067412 | Completed | N/A | Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad | August 1, 2022 | January 31, 2023 |
| NCT00114569 | Completed | Phase 1 | Lorazepam for the Treatment of Status Epilepticus in Children | March 2005 | February 2009 |
| NCT03562351 | Completed | N/A | Seizure Rescue Medication: Caregiver Education in a Simulation Setting | July 1, 2018 | September 17, 2019 |
| NCT03742167 | Completed | N/A | Pilot Simulation RCT of Telemedical Support for Paramedics | December 18, 2018 | July 12, 2022 |
| NCT06334796 | Completed | Early Phase 1 | Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology | October 1, 2023 | January 1, 2024 |
| NCT00621478 | Completed | Phase 2/Phase 3 | Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) | February 2008 | May 2012 |
| NCT00735527 | Completed | Phase 3 | Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children | May 2008 | April 2009 |
| NCT00809146 | Completed | Phase 3 | Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications | June 2009 | January 2011 |
| NCT01796574 | Completed | N/A | Ketogenic Diet for Refractory Status Epilepticus | November 2012 | March 2017 |
| NCT01870024 | Completed | Phase 3 | Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus | June 26, 2013 | February 23, 2018 |
| NCT02056236 | Completed | N/A | TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation | April 2014 | January 24, 2022 |
| NCT02239380 | Completed | Phase 3 | Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan | November 2014 | August 2016 |
| NCT00116064 | Completed | Phase 3 | Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions | July 2004 | June 2005 |
| NCT02381977 | Completed | Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment | November 2011 | September 2014 | |
| NCT02383745 | Completed | EEG in In-hospital Patients With Seizure or Altered Mental State | December 1, 2014 | December 18, 2018 | |
| NCT00004297 | Completed | Phase 3 | Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus | November 1995 | February 1999 |
| NCT05647525 | Completed | The Etiology of New-onset Status Epilepticus | January 1, 2021 | September 30, 2022 | |
| NCT05259891 | Completed | eegCap Application in Paediatrics wiTh redUced GCS in REsus | July 5, 2021 | June 20, 2022 | |
| NCT02958605 | Completed | N/A | Smartphone Apps for Pediatric Resuscitation | November 2016 | September 2017 |
| NCT02995759 | Completed | Creation, Implementation, and Analysis of a Seizure Action Plan | June 2015 | April 30, 2019 | |
| NCT04926844 | Completed | Phase 2 | Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children | June 20, 2021 | September 1, 2022 |
| NCT04679623 | Completed | Phase 1 | Study of Midazolam in Healthy Adults | June 9, 2021 | September 17, 2021 |
| NCT03350035 | Completed | Phase 2 | Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus | February 19, 2018 | September 18, 2019 |
| NCT04496076 | Completed | COVID-19 Brain Injury | April 2, 2020 | May 31, 2021 | |
| NCT06403150 | Enrolling by invitation | Phase 4 | The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus | May 15, 2023 | October 2024 |
| NCT06100978 | Not yet recruiting | Patient-reported Outcome and Patient-reported Experience After Status Epilepticus | March 1, 2024 | July 2026 | |
| NCT06441760 | Not yet recruiting | N/A | Simulation Trial of Telemedical Support for Paramedics | July 2024 | December 2028 |
| NCT05934903 | Recruiting | N/A | Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus | August 31, 2023 | July 2025 |
| NCT03457831 | Recruiting | Status Epilepticus in the Critically Ill Patients | February 28, 2018 | December 31, 2028 | |
| NCT03883516 | Recruiting | N/A | Improving Emergency Management of Status Epilepticus | September 30, 2019 | December 2024 |
| NCT04421846 | Recruiting | N/A | Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis | November 25, 2020 | June 1, 2027 |
| NCT05140265 | Recruiting | De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information | October 11, 2021 | December 31, 2030 | |
| NCT05246566 | Recruiting | Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana | May 15, 2022 | April 30, 2024 | |
| NCT05418634 | Recruiting | Point-of-care EEG in the Pediatric Emergency Department | August 24, 2022 | September 1, 2025 | |
| NCT05491590 | Recruiting | Patient-reported Outcome After Status Epilepticus | November 9, 2022 | March 1, 2024 | |
| NCT05591508 | Recruiting | N/A | Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus | November 1, 2022 | November 30, 2024 |
| NCT05674552 | Recruiting | Phase 2/Phase 3 | Exogenous Ketone Esters for Refractory Status Epileptics | January 10, 2023 | July 1, 2024 |
| NCT05756621 | Recruiting | Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest | January 15, 2022 | September 30, 2024 | |
| NCT05839418 | Recruiting | Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE) | March 1, 2023 | December 31, 2028 | |
| NCT05851391 | Recruiting | Phase 2 | buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest | August 7, 2023 | April 30, 2025 |
| NCT06017973 | Recruiting | N/A | The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus | October 1, 2023 | September 30, 2027 |
| NCT06067750 | Recruiting | Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation | June 27, 2023 | June 30, 2024 | |
| NCT06194747 | Recruiting | N/A | Improving Status Epilepticus Treatment Times | February 1, 2024 | March 31, 2027 |
| NCT04170491 | Suspended | N/A | EEG Monitoring for Refractory Status Epilepticus | March 17, 2020 | January 2027 |
| NCT02560597 | Terminated | N/A | Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy | February 3, 2015 | September 2018 |
| NCT02431663 | Terminated | Phase 3 | Ketamine in Refractory Convulsive Status Epilepticus | April 2015 | March 31, 2020 |
| NCT00343096 | Terminated | Phase 3 | Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children. | June 2006 | March 2009 |
| NCT03154307 | Terminated | N/A | Repeated TMS at Low Frequencies to Reduce Seizure Occurrence | February 19, 2016 | August 23, 2019 |
| NCT03819543 | Terminated | N/A | SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus | July 15, 2019 | August 31, 2021 |
| NCT00265616 | Terminated | Phase 3 | Treatment of Refractory Status Epilepticus | May 2006 | March 2010 |
| NCT05267405 | Unknown status | Mainz Epilepsy Registry | February 1, 2018 | January 31, 2024 | |
| NCT00362141 | Unknown status | Phase 2 | Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus | October 2006 | April 2008 |
| NCT02344706 | Unknown status | Diagnostic Value of Prehospital EEG in Non-convulsive Status Epilepticus | December 1, 2018 | January 1, 2022 | |
| NCT03378687 | Unknown status | A Clinical Study of Children With Status Epilepticus in China | September 2016 | September 2019 | |
| NCT03245099 | Unknown status | Management of Non Convulsive Status Epilepticus | December 2017 | April 2019 | |
| NCT04829838 | Unknown status | Phase 4 | Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus | July 25, 2019 | July 26, 2021 |
| NCT01268904 | Unknown status | Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures | January 2011 | August 2013 | |
| NCT05757544 | Withdrawn | Phase 2 | Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE) | April 1, 2023 | February 2026 |
| NCT04758052 | Withdrawn | N/A | Tracheostomy With Bedside Simultaneous Gastrostomy Vs Usual Care Tracheostomy And Delayed Gastrostomy Placement | March 31, 2021 | August 2022 |
| NCT02726867 | Withdrawn | Phase 3 | Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus | February 2014 | November 2016 |
| NCT05000320 | Withdrawn | VIGAB-BIOSTAT: Neuronal Injury Panel Substudy | January 2023 | August 17, 2024 |
- Disase is a (Disease Ontology)
- DOID:1826
- Cross Reference ID (Disease Ontology)
- GARD:10191
- Cross Reference ID (Disease Ontology)
- MESH:D013226
- Cross Reference ID (Disease Ontology)
- NCI:C85079
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155039002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0038220
- Exact Synonym (Disease Ontology)
- Grand mal status
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002133
- ICD10 preferred id (Insert disease from ICD10)
- D0005360
- ICD10 class code (Insert disease from ICD10)
- G41
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013226